Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial update for F01 in moderate-to-severe refractory systemic lupus erythematosus; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
A clinical trial is recruiting to investigate neutrophil extracellular traps in systemic sclerosis and related connective tissue diseases, s…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial to evaluate the safety and efficacy of ATHENA CAR-T in subjects with systemic lupus erythematosus; the study is not y…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Neutrophil Extracellular Traps in Systemic Sclerosis [NA]
A completed clinical study investigating neutrophil extracellular traps in patients with systemic sclerosis and systemic lupus erythematosus…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Prospective Study of Rapamycin for the Treatment of SLE [Phase 2]
A Phase 2 prospective trial evaluating rapamycin for systemic lupus erythematosus has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Transcriptional and Immune Parameters of Response to Belimumab
This completed study analyzes transcriptional and immune parameters associated with response to belimumab in systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital
A clinical trial at Sohag University Hospital is studying neuropsychiatric disorders in children with systemic lupus erythematosus and is cu…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients [Phase 2]
Phase 2 trial assessing the efficacy and safety of VAY736 and CFZ533 in systemic lupus erythematosus has completed with results posted in 20…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Anemia in Systemic Lupus Erythematosus Specially Refractory Type
Clinical trial update indicates a NOT_YET_RECRUITING study sponsored by Assiut University investigating refractory anemia in systemic lupus …
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE [Phase 1, Phase 2]
Phase 1b/2a study evaluating safety and efficacy of KPG-818 in systemic lupus erythematosus has completed.
-
FDA approval · 2024-05-20FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for hydroxychloroquine sulfate from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This clinical trial update covers the safety and potential efficacy of anti-CD19 CAR-T cells for relapsed/refractory autoimmune diseases, wi…
-
FDA approval · 2024-05-16FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for BENLYSTA (belimumab) filed by GlaxoSmithKline LLC.
-
FDA approval · 2024-05-16FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for BENLYSTA (belimumab) from GlaxoSmithKline, indicating an updated label or expanded indicatio…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Stress, Inflammation and Immune Response Pilot Study- Aim 3 [EARLY_Phase 1]
This early-phase Phase 1 pilot trial investigates how stress, inflammation, and immune response interact in systemic lupus erythematosus, an…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
A preliminary Phase 1 study is planned to evaluate UTAA09 injections for relapsed/refractory autoimmune diseases, with recruitment not yet s…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients
This clinical trial investigates whether the fibrinogen to albumin ratio and the C-reactive protein to albumin ratio can serve as predictive…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
This document summarizes a tissue repository that provides annotated biospecimens for investigator-directed biomedical research, with ongoin…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)
This clinical trial investigates the relationship between data from the LuGENE Multiparameter Transcriptomics Blood Test and clinical and st…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Methyl-donor Nutrient Supplementation and Methylation Profile in Lupus Patients With Obesity [NA]
A clinical trial update notes that enrollment is ongoing by invitation for a study evaluating methyl-donor nutrient supplementation and meth…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
This entry reports a clinical trial evaluating electroencephalogram recording in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2024-04-23Clinical Trial Update: A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial of LY3471851 in adults with systemic lupus erythematosus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial investigating telitacicept plus low-dose IL-2 for efficacy and immunological effects in systemic lupus erythematosus,…
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 trial evaluating TAK-079 in combination with standard therapy in moderate to severe systemic lupus erythematosus; study completed wi…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 study evaluating subcutaneous belimumab in pediatric patients with systemic lupus erythematosus. The study results were posted on 20…